<?xml version="1.0" encoding="UTF-8"?>
<p>The most commonly reported arrhythmia in COVID‚Äê19 disease is symptomatic/asymptomatic tachycardia. Bradycardia has been also reported. Arrythmia may occur in the setting of myocarditis, myocardial ischemia and in critically ill patients with hypoxia and shock.
 <xref rid="clc23406-bib-0023" ref-type="ref">
  <sup>23</sup>
 </xref> Other forms of arrythmias have been reported. Several mechanisms may trigger or aggravate arrhythmias in subjects with COVID 19. Potential causes include electrolyte disturbance (mainly hypokalemia), adverse effects of therapies (eg, chloroquine/hydroxychloroquine and azithromycin) that prolong QT interval with potential development of polymorphic ventricular tachycardia (VT)
 <xref rid="clc23406-bib-0024" ref-type="ref">
  <sup>24</sup>
 </xref> and fever which may unmask cases of cardiac channelopathies such as Brugada syndrome and long QT syndrome.
 <xref rid="clc23406-bib-0006" ref-type="ref">
  <sup>6</sup>
 </xref>
</p>
